1498-P: Optimizing the Clinical Integration of a Patient and Professional Codesigned Diabetic Ketoacidosis (DKA) Educational Infographic in Routine Care: Findings from Implementation Focus Groups

Introduction and Objective: Current DKA education tools are difficult to use and teach. Through our prior research, we created a simple DKA core educational infographic (Figure 1) with 52 patient partners, caregivers and healthcare professionals (HP). We now aimed to explore practical strategies to support its broad implementation. Methods: We used qualitative implementation science methods centered on virtual focus groups and semi-structured interviews with individuals living with T1D and HP, guided by user-centered design principles. Transcripts were analyzed using inductive thematic content analysis to identify key themes. Results: The study recruited a total of 16 participants (8 females, 8 males, mean age 41) across 12 data-collection sessions. The results identified key preferences for implementation of the infographic: A. Waiting room placement in emergency departments, endocrinology clinics, family medicine clinics and pharmacies; B. Digital access such as QR codes, websites or mobile applications; C. During diabetes visits facilitated by a conversation guide. Conclusion: The study offers insights into implementing an effective educational tool across diverse clinical settings. We recognize that implementation is an iterative, context-dependent process, therefore we present this core infographic as a flexible foundation adaptable to current clinical practice. Disclosure M.T. Cheema: None. W. Cheema: None. M. Waniss: None. D.D. Mumford: None. N. Verhoeff: None. H. Gad: Consultant; Current; Procter & Gamble. E. Parikh: None. P. Bapat: None. Y. Zhang: None. A. Orszag: None. L. Lovblom: None. K. Lamb: None. A. Jain: Other - Advisory panel, speaker's bureau, research support; Current; Abbott, Eli Lilly and Company, Novo Nordisk, Sanofi. Research Support; Current; AstraZeneca. Other - Advisory panel, speaker's bureau; Current; Dexcom, Inc., Eisai Co., Ltd., embecta. Research Support; Current; Roche Canada. Advisory Panel; Current; Boehringer Ingelheim International GmbH. A. Weisman: None. N. Ivers: None. B. Perkins: Advisory Panel; Current; Abbott Diabetes. Other - CME event speaker; Ended; Bayer AG, Dexcom, Inc. Advisory Panel; Ended; Insulet Corporation. Advisory Panel; Current; Novo Nordisk A/S. Other - Advisory and CME event speaker; Current; Sanofi. Research Support; Current; Vertex Pharmaceuticals Incorporated, Zucara Therapeutics.